| Clara Hyland-williams, NP | |
|
39 Nott Highway, Suite 5, Ashford, CT 06278 | |
| (860) 477-1267 | |
| Not Available |
| Full Name | Clara Hyland-williams |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 39 Nott Highway, Suite 5, Ashford, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194492694 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 9927 (Connecticut) | Primary |
| Entity Name | Dermatology Associates Of Eastern Ct Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952481418 PECOS PAC ID: 8628020757 Enrollment ID: O20050216000598 |
News Archive
Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest.
A team of researchers at the Institute of Oncology Research has identified a new class of regulatory RNAs, which are able to act as molecular switches and can contribute in controlling the genetic evolution processes that are responsible for some cancer pathologies.
Tohoku University Graduate School of Medicine and Tohoku Medical Megabank Organization are pleased to announce the published results of a study into why air pollutants cause some people to be more susceptible to atopic dermatitis, a kind of skin inflammation.
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clara Hyland-williams, NP 39 Nott Hwy Suite 5, Ashford, CT 06278-1341 Ph: () - | Clara Hyland-williams, NP 39 Nott Highway, Suite 5, Ashford, CT 06278 Ph: (860) 477-1267 |
News Archive
Inovio Pharmaceuticals, Inc. announced it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science Inc., an international DNA vaccine manufacturer in which Inovio holds a minority interest.
A team of researchers at the Institute of Oncology Research has identified a new class of regulatory RNAs, which are able to act as molecular switches and can contribute in controlling the genetic evolution processes that are responsible for some cancer pathologies.
Tohoku University Graduate School of Medicine and Tohoku Medical Megabank Organization are pleased to announce the published results of a study into why air pollutants cause some people to be more susceptible to atopic dermatitis, a kind of skin inflammation.
The National Institutes of Health is launching the first integrated, drug development pipeline to produce new treatments for rare and neglected diseases. The $24 million program jumpstarts a trans-NIH initiative called the Therapeutics for Rare and Neglected Diseases program, or TRND.
› Verified 6 days ago
Ms. Brittany Decarli, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 39 Nott Hwy Unit 5, Ashford, CT 06278 Phone: 860-477-0523 | |
Misty Rose Doering, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 39 Nott Hwy Unit 4, Ashford, CT 06278 Phone: 860-840-1058 Fax: 860-254-6026 |